# Revised artifact

# PRD: New Feature with Weak Evidence

## Summary
Recommend a staged evidence triage and validation path, not full feature commitment. The case packet contains no supporting evidence, which means this PRD cannot justify broad development from the materials provided. That does not prove no evidence exists elsewhere in the organization; it means the decision is currently under-supported and should begin with evidence collection from existing sources before any new pilot build is approved.

## Problem
A proposed feature is under consideration, but the materials in scope do not establish:
- who the target user is
- what concrete problem or workflow pain exists
- how severe or frequent that pain is
- whether the proposed feature is the right intervention
- whether expected impact justifies delivery cost

## Goal
Determine whether the feature merits full product investment, using the cheapest credible evidence path first.

## Non-Goals
- committing to general availability
- promising adoption or revenue outcomes
- locking implementation details before problem validation
- running a new pilot if existing organizational evidence is already sufficient to make a stop or refine decision

## Hypothesis
If we first audit existing evidence sources and only run net-new validation where gaps remain, we can make a better investment decision at lower cost than defaulting immediately to full delivery or a broad discovery sprint.

## Target User
Unknown from the case packet. Must be identified from existing internal evidence or targeted discovery.

## User Story
As a user with a currently unverified workflow pain, I want a better way to complete the relevant task so that I can reduce friction, time, or error.

## Proposed Scope
Phase 0: evidence triage
- review existing analytics, support tickets, sales feedback, research notes, and competitive inputs
- determine whether credible evidence already exists for the problem, segment, and likely value
- decide whether to stop, refine, or proceed to validation

Phase 1: targeted validation only if material gaps remain
- one bounded use case
- one target segment
- one lightweight validation method
- explicit instrumentation and decision thresholds

## Requirements
1. Inventory existing organizational evidence before approving any build work.
2. Define the target user and job-to-be-done using that evidence or focused discovery.
3. Document the current workflow and the specific pain point the feature is meant to solve.
4. If gaps remain, run the minimum viable validation needed to test problem-solution fit.
5. Instrument exposure, activation, repeat usage, and qualitative feedback for any pilot.
6. Review evidence against predefined thresholds before expanding scope.

## Success Metrics
At this stage, success is evidence quality, not launch scale:
- a target segment is clearly identified
- the problem is confirmed by existing evidence or targeted validation
- the current workaround and pain severity are documented
- the team can make a clear continue, revise, or stop decision
- any pilot users show credible value above the status quo

## Risks
- mistaking an incomplete packet for proof that no evidence exists
- duplicating research the organization already has
- building for an unimportant or infrequent problem
- allowing sunk-cost bias to turn validation into commitment
- using weak positive feedback as a substitute for demonstrated value

## Launch Approach
No general launch approval at this stage.

Recommended sequence:
1. Evidence triage from existing internal sources.
2. If evidence is still insufficient, run a gated pilot with a very small cohort.
3. Expand only if predefined validation thresholds are met.

## Decision Frame
Decision to make: whether to approve full feature development now.

Recommended decision: do not approve full development yet. Approve evidence triage first, then a narrowly scoped validation step only if meaningful gaps remain after reviewing existing sources.

Why this is the right decision:
- The case packet does not contain sufficient evidence for a full investment decision.
- Packet incompleteness is not the same as proof of no real-world evidence, so the first step should be to inspect existing organizational signals.
- A staged path improves decision usefulness by minimizing unnecessary work while preserving the option to proceed quickly if evidence already exists.

## Unknowns & Evidence Gaps
- Whether internal analytics already show demand or repeated workflow failure
- Whether support, sales, or research data already identify the target segment and pain severity
- Whether competitors or substitutes make this feature table stakes
- Expected business impact if the problem is real
- Technical feasibility, cost, and operational complexity
- The evidence threshold required to move from validation to full PRD

## Pass/Fail Readiness
Current status: Fail for full feature commitment.

Pass conditions for advancing to a full build PRD:
- existing evidence sources have been audited
- target segment is identified
- problem severity is validated through credible evidence
- pilot scope and success/failure thresholds are agreed in advance if a pilot is still needed
- results support a clear investment case

## Recommended Next Artifact
Evidence triage and validation plan, including:
- internal evidence inventory
- target segment definition
- gap analysis of what is known vs unknown
- validation method only for unresolved gaps
- decision thresholds for continue, revise, or stop
